Form 4: Thrive Capital Increases Stake in Oscar Health Through Multiple Share Purchases

Thrive Capital, through various entities, has significantly increased its holdings in Oscar Health by purchasing shares over three consecutive days.

Summary

• Thrive Capital, through its affiliated entities, has acquired a substantial number of Class A Common Stock shares of Oscar Health, Inc.
• The purchases occurred over three days, from November 11, 2024, to November 13, 2024.
• On November 11, 2024, 276,040 shares were purchased at a weighted average price of $13.5779.
• On November 12, 2024, 420,819 shares were purchased at a weighted average price of $13.6772.
• On November 13, 2024, 358,619 shares were purchased at a weighted average price of $13.7369.
• These transactions increased Thrive Capital's total indirect holdings to 5,810,700 shares.
• The purchases were made by Thrive Capital Partners VII Growth, L.P. and Claremount VII Associates, L.P., with Thrive Partners VII Growth GP, LLC and Thrive Partners VII GP, LLC acting as general partners.
• Joshua Kushner, as the managing member of the general partners, has voting and investment power over these shares.

Sentiment

Score: 7

Explanation: The document indicates a positive move by a major investor, suggesting confidence in the company. However, it is a standard filing and does not contain any information about the overall health of the company.

Positives

• Thrive Capital's increased investment signals confidence in Oscar Health's future prospects.
• The consistent purchases over three days suggest a strategic long-term investment approach.
• The purchases were made in compliance with regulatory requirements, indicating a disciplined approach.

Risks

• The document does not explicitly state any risks, but the increased stake could be a risk if Oscar Health's performance declines.
• The document does not provide any information about the overall market conditions or the health of the company.

Management Comments

• Joshua Kushner has been deputized to represent the Reporting Persons on the board of directors of the Issuer.
• Each of the Reporting Persons may be deemed directors by deputization of the Issuer.

Industry Context

This filing indicates a significant investment by a major shareholder, which could be seen as a positive signal for the company's prospects within the health insurance industry. It is common for large investors to increase their stake in companies they believe in.

Comparison to Industry Standards

• It is common for large investment firms like Thrive Capital to increase their holdings in companies they believe have growth potential.
• The share purchases are in line with standard practices for institutional investors, using weighted average prices and adhering to Rule 10b-18.
• Other similar investment firms such as Tiger Global or Softbank often make similar moves in their portfolio companies.

Stakeholder Impact

• The increased investment by Thrive Capital could be viewed positively by shareholders, potentially increasing confidence in the company.
• The increased stake could also be viewed positively by employees as it signals confidence in the company's future.

Key Dates

Keywords

Oscar Health, Thrive Capital, Share Purchase, Class A Common Stock, Beneficial Ownership, Joshua Kushner, Rule 10b-18, Investment